GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Orchard Therapeutics plc Stock and on which exchange is it traded?
The symbol for Orchard Therapeutics plc is ORTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Orchard Therapeutics plc Stock?
Orchard Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Orchard Therapeutics plc Stock?
Orchard Therapeutics plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Orchard Therapeutics plc Stock.

What's the current price of Orchard Therapeutics plc Stock?
As of the end of day on the 2024-03-15, the price of an Orchard Therapeutics plc (ORTX) share was $16.70.

What is the 52-week high and low for Orchard Therapeutics plc Stock?
The 52-week high for Orchard Therapeutics plc Stock is $16.72 and the 52-week low is $4.24.

What is the market capitalization of Orchard Therapeutics plc Stock?
As of the 2024-03-15, the market capitalization of Orchard Therapeutics plc is 380.109M.

When is the next earnings date for Orchard Therapeutics plc?
The upcoming earnings date for Orchard Therapeutics plc is May 13, 2024.
Click to get the best stock tips daily for free!

About Orchard Therapeutics plc

Orchard Therapeutics plc Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the... ORTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT